Combining them may push heart rate, blood pressure, and arrhythmia risk beyond what either produces alone, which matters most for anyone with existing cardiac risk
Only a few reports of SSP-MMNST have been described
However, research is varied on which one is the "best." According to a 2024 systematic review and meta-analysis, the combination GIP/GLP-1 receptor agonist tirzepatide was found to be the most effective at controlling blood sugar
doi:10.1371/journal.pone.0042357 Camacho-Pereira J, Tarrag MG, Chini CCS, et al
Their health profiles could not be more different
We have won the trust and support of its customers with its excellent service quality and efficient operating capabilities